ReviewCurrent microbiology2023

Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection.

Anupriya Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.